A small percentage of individuals with alcohol use disorder (AUD) obtain alcohol-related care despite research showing that treatment is effective. This randomized controlled trial tests the efficacy of a brief, phone based cognitive behavioral intervention to increase treatment engagement, improve alcohol related outcomes, and show that treatment engagement is a mechanism for the improved outcomes in individuals with AUD.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06860607 — Environment and Alcohol: A Pilot Study
· Phase 1
· recruiting
NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder
· Phase 2
· recruiting
NCT07046819 — Tirzepatide in MetALD
· Phase 2
· recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes
· Phase 2
· recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
· NA
· recruiting
Other University of Rochester trials
Trials by the same sponsor.
NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1
· Phase 1
· not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi
· Phase 2
· not yet recruiting
NCT05744869 — SBAT for Health Equity
· NA
· not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
· Phase 2
· not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 4 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03758274.